Improved intranasal immunization with live-attenuated measles virus after co-inoculation of the lipopeptide MALP-2
Authors:
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Evaluation of immunogenicity and side effects of triple viral vaccine (MMR) in adults, given by two routes: subcutaneous and respiratory (aerosol)Vaccine, 2005
- Synthetic lipopeptide adjuvants and Toll-like receptor 2—structure–activity relationshipsVaccine, 2004
- Immunologic studies of specific mucosal and systemic immune responses in Mexican school children after booster aerosol or subcutaneous immunization with measles vaccineVaccine, 2004
- Induction of Cellular and Humoral Immunity after Aerosol or Subcutaneous Administration of Edmonston‐Zagreb Measles Vaccine as a Primary Dose to 12‐Month‐Old ChildrenThe Journal of Infectious Diseases, 2004
- Successful mucosal immunization of cotton rats in the presence of measles virus-specific antibodies depends on degree of attenuation of vaccine vector and virus doseJournal of General Virology, 2003
- Efficient mucosal delivery of the HIV‐1 Tat protein using the synthetic lipopeptide MALP‐2 as adjuvantEuropean Journal of Immunology, 2003
- Hemagglutinin Protein of Wild-Type Measles Virus Activates Toll-Like Receptor 2 SignalingJournal of Virology, 2002
- Cytokine and Chemokine Gene Expression after Primary and Secondary Respiratory Syncytial Virus Infection in Cotton RatsThe Journal of Infectious Diseases, 2002
- Recruitment of Lymphocytes and Dendritic Cells from the Blood to the Bronchoalveolar Space and the Draining Lymph Nodes after a Single Intrabronchial Application of the Lipopeptide MALP-2Pathobiology, 2002
- Regulation of Antibody Responses via Antibodies, Complement, and Fc ReceptorsAnnual Review of Immunology, 2000